mariam faiz (17 risultati)

Condizione: New. pp. 84.

Paperback. Condizione: Brand New. 244 pages. 8.66x5.91x0.55 inches. In Stock.

Taschenbuch. Condizione: Neu. Genetic Changes and Their Prognostic Impact In Leukaemia Patients | Characterization of Cytogenetic and Molecular Genetic Changes and Their Prognostic impact in Acute Leukaemia Patients | Mariam Faiz (u. a.) | Taschenbuch | 244 S. | Englisch | 2017 | LAP LAMBERT Academic Publishing | EAN 9783330014077 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.

Paperback. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Paperback. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Paperback. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

paperback. Condizione: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Condizione: New. Print on Demand pp. 84 2:B&W 6 x 9 in or 229 x 152 mm Perfect Bound on Creme w/Gloss Lam.

Condizione: New. PRINT ON DEMAND pp. 84.

Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Rashid FarzanaDr Farzana Rashid is Associate Professor at the Lahore University. She has 14 international and national research articles and 4 international books on her credit in the field of biotechnology, microbiology and educatio.

Kartoniert / Broschiert. Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Rashid FarzanaDr Farzana Rashid is Associate Professor at the Lahore University. She has 14 international and national research articles and 6 international books on her credit in the field of biotechnology, microbiology and educatio.

Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -In Pakistan comprehensive data from population based studies on the incidence of childhood leukaemia is generally lacking. In developing countries, treatment of acute lymphoblastic leukaemia (ALL) usually relies on different immunophenotypic, cytogenetic and molecular subsets that have differing outcomes with different therapies. In Pakistan, treatment offered to patients is usually based on clinical features of disease at presentation. This book attempts to identify and characterize different risk factors and clinical and genetic prognostic markers in Pakistan ALL patients.Moreover, classification of patients into different risk groups and effects of conventional therapies on treatment outcome were also studied.The importance of research to identify the optimal therapy for children with ALL including well designed clinical trials, identification of higher risk features with appropriate treatment changes and tailoring of therapy according to response and riskgroups are emphasized 244 pp. Englisch.

Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Faiz MariamDr Mariam Faiz is Principal Scientist at Institute of Nuclear Medicine and Oncology, Lahore, Pakistan. Dr Faiz currently supervises the Department of clinical pathology of the institute. Her field of interest is cancer gen.

Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Faiz MariamDr. Mariam Faiz is Principal Scientific Officer at Institute of Nuclear Medicine and Oncology. Dr. Faiz supervises molecular diagnosis part of the clinical pathology department of the institute. Dr. Javed Iqbal Qazi is .

Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -In Pakistan comprehensive data from population based studies on the incidence of childhood leukaemia is generally lacking. In developing countries, treatment of acute lymphoblastic leukaemia (ALL) usually relies on different immunophenotypic, cytogenetic and molecular subsets that have differing outcomes with different therapies. In Pakistan, treatment offered to patients is usually based on clinical features of disease at presentation. This book attempts to identify and characterize different risk factors and clinical and genetic prognostic markers in Pakistan ALL patients.Moreover, classification of patients into different risk groups and effects of conventional therapies on treatment outcome were also studied.The importance of research to identify the optimal therapy for children with ALL including well designed clinical trials, identification of higher risk features with appropriate treatment changes and tailoring of therapy according to response and riskgroups are emphasizedVDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 244 pp. Englisch.

Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - In Pakistan comprehensive data from population based studies on the incidence of childhood leukaemia is generally lacking. In developing countries, treatment of acute lymphoblastic leukaemia (ALL) usually relies on different immunophenotypic, cytogenetic and molecular subsets that have differing outcomes with different therapies. In Pakistan, treatment offered to patients is usually based on clinical features of disease at presentation. This book attempts to identify and characterize different risk factors and clinical and genetic prognostic markers in Pakistan ALL patients.Moreover, classification of patients into different risk groups and effects of conventional therapies on treatment outcome were also studied.The importance of research to identify the optimal therapy for children with ALL including well designed clinical trials, identification of higher risk features with appropriate treatment changes and tailoring of therapy according to response and riskgroups are emphasized.

Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - In Pakistan, comprehensive data from population based studies on the incidence of childhood leukaemia is generally lacking. In developing countries, treatment of acute lymphoblastic leukaemia (ALL) usually relies on different immunophenotypic, cytogenetic and molecular subsets that have differing outcomes with different therapies. In Pakistan, treatment offered to patients is usually based on clinical features of disease at presentation. This books attempts to identify and characterize different risk factors and clinical and genetic prognostic markers in Pakistani ALL patients. Moreover, classification of patients into different risk groups and effects of conventional therapies on treatment outcome were also studied. The importance of research to identify the optimal therapy for children with ALL including well-designed clinical trials, identification of higher risk features with appropriate treatment changes and tailoring of therapy according to response and risk groups are emphasized.